APOTHEEK WOSTYN
ActiveAPOTHEEK WOSTYN has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €354k and a net result of €38k. Equity remains stable across the filed fiscal years (±1.7% per year). Its solvency ranks better than 91% of 10331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability80▼-5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 5.41 against 3.96 in 2024; short-term debt: 16.8% and cash: 21.1% of total assets), and 16.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
83.2%
Return on assets
8.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €354k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-05-2026, 65 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
65 d early
2024
7 d early
2023
28 d early
2022
13 d early
2021
11 d early
2020
27 d late
2019
69 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€354k▲ 0.9%
2024 · €350k
2018: €284k
2019: €318k
2020: €344k
2021: €415k
2022: €340k
2023: €292k
2024: €350k
2018 → 2025
Total assets
€425k▼ 7.9%
2024 · €462k
2018: €523k
2019: €494k
2020: €511k
2021: €494k
2022: €438k
2023: €420k
2024: €462k
2018 → 2025
Net result
€38k▼ 36.0%
2024 · €59k
2018: €-12k
2019: €38k
2020: €26k
2021: €75k
2022: €-38k
2023: €53k
2024: €59k
2018 → 2025
Working capital
€314k▼ 0.7%
2024 · €317k
2018: €414k
2019: €361k
2020: €308k
2021: €300k
2022: €315k
2023: €257k
2024: €317k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€415k-€340k▼ 18.1%€292k▼ 14.0%€350k▲ 20.0%€354k▲ 0.9%
Operating result€105k-€-16k€77k€90k▲ 16.4%€56k▼ 37.5%
Net result€75k-€-38k€53k€59k▲ 10.8%€38k▼ 36.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 37% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €425k
Fixed assets
€40k▲ 2.8%
Current assets
€386k▼ 8.9%
Equity and liabilities €425k
Equity
€354k▲ 0.9%
Debt
€71k▼ 35.9%
The debt ratio falls from 24.1% to 16.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€63k▼
2024 · €96k
Cash flow
€45k▼
2024 · €65k
Solvency
83.2%▲
2024 · 75.9%
Current ratio
5.41▲
2024 · 3.96
Quick ratio
2.80▲
2024 · 2.32
Debt / equity
0.20▼
2024 · 0.32
ROE
10.7%▼
2024 · 16.9%
ROA
8.9%▼
2024 · 12.8%
Interest coverage
9.75▲
2024 · 9.07
Debt
€71k▼
2024 · €111k
Debt ≤ 1 year
€71k▼
2024 · €107k
Income taxes
€16k▼
2024 · €24k
Staff costs
€127k▲
2024 · €101k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€462k€425k▼
Fixed assets21/28€38k€40k▲
Tangible fixed assets22/27€36k€37k▲
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€974€153▼
Other tangible fixed assets26€32k€35k▲
Financial fixed assets28€3k€3k=
Current assets29/58€423k€386k▼
Amounts receivable after more than one year29€85k€85k=
Other amounts receivable291€85k€85k=
Stocks and contracts in progress3€175k€186k▲
Stocks30/36€175k€186k▲
Amounts receivable within one year40/41€13k€22k▲
Trade receivables40€13k€9k▼
Other amounts receivable41€3€12k▲
Cash at bank and in hand54/58€146k€90k▼
Deferred charges and accrued income490/1€4k€3k▼
Equity and liabilities
Total equity and liabilities10/49€462k€425k▼
Equity10/15€350k€354k▲
Contributions10/11€100k€100k=
Reserves13€250k€254k▲
Distributable reserves133€250k€254k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€111k€71k▼
Amounts payable within one year42/48€107k€71k▼
Trade debts44€36k€41k▲
Suppliers440/4€36k€41k▲
Taxes, remuneration and social security45€33k€30k▼
Taxes450/3€11k€3k▼
Remuneration and social security454/9€22k€27k▲
Other amounts payable47/48€38k€0▼
Accrued charges and deferred income492/3€5k€106▼
Income statement
Code20242025
Remuneration, social security and pensions62€101k€127k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6k€7k▲
Other operating charges640/8€4k€4k▼
Gross operating margin9900€202k€194k▼
Operating profit (loss)9901€90k€56k▼
Financial income75/76B€4k€4k▲
Recurring financial income75€4k€4k▲
Financial charges65/66B€11k€6k▼
Recurring financial charges65€11k€6k▼
Profit (loss) for the period before taxes9903€83k€54k▼
Income taxes67/77€24k€16k▼
Profit (loss) for the period9904€59k€38k▼
Profit (loss) for the period to be appropriated9905€59k€38k▼
Appropriation of the result
Profit (loss) to be appropriated9906€59k€38k▼
Profit (loss) brought forward from the previous period14P€0-
Transfer from equity791/2-€35k
Transfer to equity691/2€58k€38k▼
To other reserves6921€58k€38k▼
Profit to be distributed694/7€859€35k▲
Return on contributions (dividend)694€859€35k▲
Social balance
Average headcount (FTE)90872.82.8=
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-05
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Back to profitnet €53k
Net result €53k after one loss-making year.
18-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet €-38k ▼151%
Net result drops to €-38k, the lowest in the series; recovery starts the following year.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Highest result since 2018net €75k ▲182%
Operating result €105k, net result €75k, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 27 days late
2020
08-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 69 days late
2019
31-12
Financial
Back to profitnet €38k
Net result €38k after one loss-making year.
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 29 days late
2018
21-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 21 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tielt · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Markt 298700 TieltGround area
357 m²
Building footprint
237 m²
Volume, LiDAR
2,563 m³
Parcel 37015K0738/00C000, Flanders · tallest building 14.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BVBA Apotheek Wostyn
since 20102.184.612.521
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 37015K0738/00C000 | Flanders | 357 m² | 1 · 237 m² | 14.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 534 EUR awarded · 573 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 156 EUR | 156 EUR |
| 2024 | 1 | 84 EUR | 84 EUR |
| 2023 | 1 | 0 EUR | 39 EUR |
| 2022 | 1 | 294 EUR | 294 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteTielt2.184.612.521
Similar companies · same sector, comparable size
PHARMACIE DEFRE
BE 0480.024.492
Celles (lez-Tournai) · Eq €354k
Apotheek Merchtem DF
BE 0447.511.379
Merchtem · Eq €354k
APOTHEEK SARAH CROUX
BE 0462.921.909
Maaseik · Eq €354k
JUNIOR INVEST
BE 0897.049.367
Jette · Eq €354k
IDESPHARMA
BE 0764.318.824
Koksijde · Eq €353k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,466 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded10-12-2009
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:katrien.wostyn@pandora.be
Phone:051/400106